Medical News

Unauthorized Marketing Leads Aesthetic Device Recalls in U.S.

Unauthorized marketing is the leading cause of aesthetic energy-based device recalls in the U.S., according to a 2026 study.

Unauthorized Marketing Leads Aesthetic Device Recalls in U.S.

A recent study presented at the American Society for Dermatologic Surgery Annual Meeting in San Diego revealed that regulatory or unauthorized marketing is the most common cause for aesthetic energy-based device recalls in the U.S. The meeting, held from November 5-8, 2026, highlighted critical insights into the safety and regulation of these devices.

The research, led by Melissa A. Levoska, MD, a dermatologist at UnionDerm, analyzed recalls of these devices from 2002 to 2026. It found that laser and light devices accounted for 64% of all recalls, though none were classified as the most serious type by the FDA. Levoska emphasized that these devices, despite their popularity in cosmetic practices, require closer scrutiny in post-market safety monitoring.

Most recalls classified as class II

The FDA designated most recalls as class II, indicating potential “temporary or medically reversible adverse health consequences,” Levoska said. Nineteen recalls were attributed to regulatory or unauthorized marketing issues, making it the leading cause. Notably, none of the recalls were designated as class I, the most severe category, which shows the relatively lower risk associated with these devices.

The study utilized the openFDA device and recall database, searching for 20 predetermined FDA product codes, 16 of which were specific to aesthetic devices. Researchers filtered through 889 raw records, identifying 74 aesthetic device recalls. This process required meticulous filtering, as non-aesthetic surgical devices were often included in the initial search results, complicating the analysis.

Laser and light devices lead in recalls

Among the recalled devices, laser and light devices accounted for 64% of cases (n = 33), followed by light and intense pulsed light devices (n = 14), radiofrequency devices (n = 9, including microneedling), and helium plasma devices (n = 8). Other recalls included cryolipolysis (n = 6), electrical muscle stimulation and high-intensity focused electromagnetic devices (n = 2), and focused ultrasound (n = 1). A single device was classified as “other,” highlighting the diversity of devices involved in recalls.

The data showed that 94% of recalls were manufacturer-initiated, with 28 distinct manufacturers involved. The top three manufacturers, Lumenis, Apyx, and Candela, accounted for 32% of the recalls. Levoska noted that this distribution indicates a field-wide pattern rather than issues isolated to specific manufacturers.

Field-wide pattern, not isolated issue

When device failures occurred, thermal issues or fires were most associated with lasers, while regulatory design issues were linked to light and intense pulsed light devices. Helium plasma devices faced manufacturing or sterility problems, and cryolipolysis recalls were primarily complaint-driven. These specific issues show the need for targeted improvements in device design and manufacturing processes.

Leave a Reply

Your email address will not be published. Required fields are marked *